Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer

Status unconfirmed · Phase 2

Conditions studied: Ovarian Cancer, Primary Peritoneal Cavity Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. IM-862 may kill tumor cells by stopping blood flow to the tumor and by stimulating a person's white blood cells to kill tumor cells. Combining chemotherapy and IM-862 may kill more tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of combination chemotherapy and IM-862 in treating patients who have resected stage III ovarian cancer or primary peritoneal cancer.

Key facts

Study ID

NCT00017303

Run by

Cytran

Starts

2001-01-01

Last updated by the study team

2013-11-06

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Comprehensive Cancer Center — Glendale, California, United States
• Community Hospital of Los Gatos — Los Gatos, California, United States
• Stanford University Medical Center — Stanford, California, United States
• Lombardi Cancer Center — Washington D.C., District of Columbia, United States
• Winship Cancer Institute — Atlanta, Georgia, United States
• University of Kansas School of Medicine-Wichita — Wichita, Kansas, United States
• University of Minnesota Cancer Center — Minneapolis, Minnesota, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• University of Nebraska Medical Center — Omaha, Nebraska, United States
• Women's Cancer Center - Las Vegas — Las Vegas, Nevada, United States
• Roswell Park Cancer Institute — Buffalo, New York, United States
• Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States
• Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio, United States
• Arthur G. James Cancer Hospital - Ohio State University — Columbus, Ohio, United States
• Magee-Womens Hospital — Pittsburgh, Pennsylvania, United States
• Fletcher Allen Health Care - Medical Center Campus — Burlington, Vermont, United States
• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States
• University of Washington School of Medicine — Seattle, Washington, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.